Non-genomic effects of nuclear receptors: insights from the anucleate platelet
Open accessThe DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Abstract
Nuclear receptors (NRs) have the ability to elicit two different kinds of responses, genomic and non-genomic. Although genomic responses control gene expression by influencing the rate of transcription, non-genomic effects occur rapidly and independently of transcriptional regulation. Due to their anucleate nature and mechanistically well-characterized and rapid responses, platelets provide a model system for the study of any non-genomic effects of the NRs. Several NRs have been found to be present in human platelets, and multiple NR agonists have been shown to elicit anti-platelet effects by a variety of mechanisms. The non-genomic functions of NRs vary, including the regulation of kinase and phosphatase activity, ion channel function, intracellular calcium levels, and production of second messengers. Recently, the characterization of mechanisms and identification of novel binding partners of NRs have further strengthened the prospects of developing their ligands into potential therapeutics that offer cardio-protective properties in addition to their other defined genomic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, NRs may also harbor non-genomic functions right after biosynthesis, which however are still yet not fully elucidated.[44]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
PPARγ signaling and metabolism: the good, the bad and the future
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3159 · Cited by 2,016
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463 · cited 1×
“The formation of different multi-protein signalling complexes with different localization and distribution patterns across different cell types could offer a high degree of cell and tissue selective action for the NRs but as of yet these are poorly defined.(10,11)”
Nuclear Receptors, RXR, and the Big Bang
Evans, R. M., & Mangelsdorf, D. J. (2014) · Cell · doi:10.1016/j.cell.2014.03.012 · Cited by 1,200
Tanaka, M., Yamamoto, Y., Misawa, E., Nabeshima, K., Saito, M., Yamauchi, K., Abe, F., & Furukawa, F. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000454718 · Cited by 1,092
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Boilard, E., Nigrovic, P. A., Larabee, K., Watts, G. F. M., Coblyn, J. S., Weinblatt, M. E., Massarotti, E. M., Remold-O’Donnell, E., Farndale, R. W., Ware, J., et al. (2010) · Science · doi:10.1126/science.1181928 · Cited by 1,085
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Glucocorticoid receptor signaling in health and disease
Kadmiel, M., & Cidlowski, J. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.003 · Cited by 849
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818 · cited 1×
“GRs are activated by glucocorticoid and anti-inflammatory hormones that regulate inflammation and glucose homeostasis.(52) Prednisolone, a synthetic glucocorticoid derived from cortisol, has been shown to .”
Emerging roles for platelets as immune and inflammatory cells
Morrell, C. N., Aggrey, A. A., Chapman, L. M., & Modjeski, K. L. (2014) · Blood · doi:10.1182/blood-2013-11-462432 · Cited by 735
Localized scleroderma-response to 1,25-dihydroxyvitamin D3
HUMBERT, P. G., DUPOND, J. L., ROCHEFORT, A., VASSELET, R., LUCAS, A., LAURENT, R., & AGACHE, P. (1990) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1990.tb02127.x · Cited by 612
Signalling role of adipose tissue: adipokines and inflammation in obesity
Trayhurn, P., & Wood, I. S. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331078 · Cited by 588 · cited 1×
“Platelets are known to act as direct contributors towards the progression of CVDs such as atherosclerosis, 86 and their activity becomes considerably enhanced in cases of hyperlipidaemia, 87 obesity, 88 diabetes mellitus, 89 or hypertension.”
Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
Lee, C.-H., Chawla, A., Urbiztondo, N., Liao, D., Boisvert, W. A., & Evans, R. M. (2003) · Science · doi:10.1126/science.1087344 · Cited by 580
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
Structural Overview of the Nuclear Receptor Superfamily: Insights into Physiology and Therapeutics
Huang, P., Chandra, V., & Rastinejad, F. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135917 · Cited by 533 · cited 1×
“As NRs can regulate the expression of multiple genes, in various cell types it is therefore highly likely that chronic exposure to NR ligands could lead to systemic effects that might indirectly affect platelet function.(75) Figure 3 Inhibition of platelet function by RAR and RXR ligands is mediated through Arp2/3- an…”
Hankey, G. J., & Eikelboom, J. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68040-9 · Cited by 505
Estrogen Signaling and Cardiovascular Disease
Murphy, E. (2011) · Circulation Research · doi:10.1161/circresaha.110.236687 · Cited by 497 · cited 1×
“Oestradiol-17b (E2) and ERs are not only well known for their role in reproductive and sexual development but also known to directly influence cardiovascular health.(53) Human platelets have been shown to express ERb but not ERa.”
Extranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475 · cited 1×
“4 The non-genomic functions of NRs vary 5–7 and whilst it is thought these functions are initiated by physical interactions of NRs with cofactors and binding partners that initiate rapid signalling events, the exact mechanisms are not well understood.”
Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease
Badimon, L., Padró, T., & Vilahur, G. (2012) · European Heart Journal: Acute Cardiovascular Care · doi:10.1177/2048872612441582 · Cited by 430 · cited 1×
“This makes them important therapeutic targets for the treatment of cardiovascular diseases, particularly atherothrombosis.(71)”
Peroxisome proliferator-activated receptors and inflammation
Moraes, L. A., Piqueras, L., & Bishop-Bailey, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.007 · Cited by 376 · cited 1×
“62 Synthetic ligands of PPAR c , the thiazolidinediones (pioglitazone, rosiglitazone, lobeglitazone, etc.), are currently in use for the treatment of type 2 diabetes and have been observed clinically to have cardio-protective properties.”
Y. Maximov, P., M. Lee, T., & Craig Jordan, V. (2013) · Current Clinical Pharmacology · doi:10.2174/1574884711308020006 · Cited by 376
Nuclear Receptor Structure: Implications for Function
Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D., & Miura, M. T. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160308 · Cited by 366 · cited 1×
“Upon activation by their lipophilic ligands, NRs regulate several fundamental biological processes, such as cell proliferation, differentiation, metabolism, and homeostasis (Table 1).(1,2) Any deviation from their normal function can lead to the pathological manifestations, such as cancer, diabetes, arthritis, and obe…”
The use of isotretinoin in acne
Layton, A. (2009) · Dermato-Endocrinology · doi:10.4161/derm.1.3.9364 · Cited by 314
Testosterone Increases Human Platelet Thromboxane A2Receptor Density and Aggregation Responses
Ajayi, A. A. L., Mathur, R., & Halushka, P. V. (1995) · Circulation · doi:10.1161/01.cir.91.11.2742 · Cited by 306 · cited 1×
“Two independent studies also confirmed that testosterone causes a significant increase in TXA2 receptor density on the platelet surface, thereby, indirectly increasing platelet responsiveness.(54,55) However, inhibition of platelet aggregation has also been observed following treatment with testosterone, although this…”
Liver X Receptor Signaling Pathways and Atherosclerosis
Calkin, A. C., & Tontonoz, P. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.191197 · Cited by 293
Sex and age differences in human platelet aggregation
JOHNSON, M., RAMEY, E., & RAMWELL, P. W. (1975) · Nature · doi:10.1038/253355a0 · Cited by 274 · cited 1×
“…aggregation response of platelets isolated from male rats was stronger in comparison to female rats owing to higher levels of androgenic steroids 46 as platelet aggregation was found to be reduced following castration in male rats and the reversal of these effects following treatment with…”
Factors Contributing to Increased Platelet Reactivity in People With Diabetes
Schneider, D. J. (2009) · Diabetes Care · doi:10.2337/dc08-1865 · Cited by 223 · cited 1×
“Platelets are known to act as direct contributors towards the progression of CVDs such as atherosclerosis, 86 and their activity becomes considerably enhanced in cases of hyperlipidaemia, 87 obesity, 88 diabetes mellitus, 89 or hypertension.”
Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds
Sundahl, N., Bridelance, J., Libert, C., De Bosscher, K., & Beck, I. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.001 · Cited by 216
The Function of Vitamin D Receptor in Vitamin D Action
Kato, S. (2000) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022662 · Cited by 216 · cited 1×
“VDR is also known to form a heterodimer with the RXR and regulate calcium homeostasis, cell growth and differentiation, detoxification of xenobiotics, and modulation of adaptive and innate immunity.(70) Although anticoagulant effects of vitamin D have been reported and VDR signalling has been characterized in monocyte…”
Khetawat, G., Faraday, N., Nealen, M. L., Vijayan, K. V., Bolton, E., Noga, S. J., & Bray, P. F. (2000) · Blood · doi:10.1182/blood.v95.7.2289 · Cited by 210
Platelets and platelet-like particles mediate intercellular RNA transfer
Risitano, A., Beaulieu, L. M., Vitseva, O., & Freedman, J. E. (2012) · Blood · doi:10.1182/blood-2011-12-396440 · Cited by 205 · cited 1×
“Moreover, there is evidence to suggest that plateletderived microparticles may deliver platelet mRNAs into other nucleated cells, such as monocytes and endothelial cells, where they then undergo translation.(19) Components of this transcription machinery found to be present inside platelets include the intracellular N…”
The role of platelet activation in tumor metastasis
Borsig, L. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.8.1247 · Cited by 199 · cited 1×
“atherosclerosis and rheumatoid arthritis),(12,13) type 2 diabetes,(14) and cancer cell metastasis).(15)”
Zimmerman, G. A., & Weyrich, A. S. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160218 · Cited by 193 · cited 1×
“75 Secondly, although, there exists a clear distinction between genomic and non-genomic effects, the existence of mRNA in platelets and their limited ability to perform translation raises the possibility 17,76 that there are interactions between NRs and mRNA in platelets as in nucleated cells.”
Akbiyik, F., Ray, D. M., Gettings, K. F., Blumberg, N., Francis, C. W., & Phipps, R. P. (2004) · Blood · doi:10.1182/blood-2004-03-0926 · Cited by 191
Effects of endogenous sex hormones on the periodontium — Review of literature
Güncü, G., Tözüm, T., & Çaglayan, F. (2005) · Australian Dental Journal · doi:10.1111/j.1834-7819.2005.tb00352.x · Cited by 186
Platelet signaling: a complex interplay between inhibitory and activatory networks
Bye, A. P., Unsworth, A. J., & Gibbins, J. M. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13302 · Cited by 186 · cited 1×
“Both natural and synthetic ligands of NRs have been shown to exhibit nongenomic effects to alter platelet function through a variety of mechanisms, several of which appear to be shared by different NR family members.(21,74) For instance, RXR, FXR, PPARa, PPARb, and PPARc receptors have been shown to be involved in the…”
Self-citationWójcicka, G., Jamróz-Wiśniewska, A., Horoszewicz, K., & Bełtowski, J. (2007) · PubMed · Cited by 179
Receptor Mechanisms Mediating Non-Genomic Actions of Sex Steroids
Boonyaratanakornkit, V., & Edwards, D. (2007) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-973427 · Cited by 178
Silvagno, F., De Vivo, E., Attanasio, A., Gallo, V., Mazzucco, G., & Pescarmona, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008670 · Cited by 164 · cited 4×
“Human platelets have been found to express the VDR. Biochemical fractionation studies along with immuno-electron microscopy analysis identified the VDR to be localized in the soluble and mitochondrial compartment.”
InfluentialMannheim Classification of Nongenomically Initiated (Rapid) Steroid Action(s)
Falkenstein, E., Norman, A. W., & Wehling, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.2072 · Cited by 162 · cited 1×
“Unlike the genomic functions, which can occur over minutes or hours, these events occur in the time frame of seconds to a few minutes, which is considered too rapid to be attributed to the biosynthesis of mRNA or protein, and is often unaffected by the inhibitors of transcription or translation.(4) The non-genomic fun…”
Kiss, M., Czimmerer, Z., & Nagy, L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.044 · Cited by 161 · cited 1×
“Upon activation by their lipophilic ligands, NRs regulate several fundamental biological processes, such as cell proliferation, differentiation, metabolism, and homeostasis (Table 1).(1,2) Any deviation from their normal function can lead to the pathological manifestations, such as cancer, diabetes, arthritis, and obe…”
The Estrogen Trinity: Membrane, Cytosolic, and Nuclear Effects
Nadal, A., Díaz, M., & Valverde, M. A. (2001) · Physiology · doi:10.1152/physiologyonline.2001.16.6.251 · Cited by 159 · cited 1×
“4 The non-genomic functions of NRs vary 5–7 and whilst it is thought these functions are initiated by physical interactions of NRs with cofactors and binding partners that initiate rapid signalling events, the exact mechanisms are not well understood.”
The molecular physiology of nuclear retinoic acid receptors. From health to disease
Duong, V., & Rochette‐Egly, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.007 · Cited by 157 · cited 2×
“RARs play a critical role in numerous biological processes, including development, reproduction, immunity, organogenesis, and homeostasis.(64) Three forms of RAR exist—RARa, RARb, and RARc.”
Developmental expression of retinoic acid receptors (RARs)
Dollé, P. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07006 · Cited by 152 · cited 1×
“Of these, RARa is ubiquitously distributed and has been reported to be robustly expressed in human platelets, whilst the other two isoforms have tissue-specific distribution.(65) RARs are activated by retinoids which are metabolites of vitamin A and several synthetic ligands also exist.”
Cecchetti, L., Tolley, N. D., Michetti, N., Bury, L., Weyrich, A. S., & Gresele, P. (2011) · Blood · doi:10.1182/blood-2010-12-324517 · Cited by 150 · cited 1×
“There is a growing consensus that these RNAs are not subjected to a random transfer by megakaryocytes but are specifically sorted and are competent for translation within platelets.(17,18) Moreover, there is evidence to suggest that plateletderived microparticles may deliver platelet mRNAs into other nucleated cells,…”
Platelets and diabetes mellitus
Santilli, F., Simeone, P., Liani, R., & Davì, G. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.05.002 · Cited by 147
Platelet mRNA: the meaning behind the message
Rowley, J. W., Schwertz, H., & Weyrich, A. S. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328357010e · Cited by 145 · cited 1×
“There is a growing consensus that these RNAs are not subjected to a random transfer by megakaryocytes but are specifically sorted and are competent for translation within platelets.(17,18) Moreover, there is evidence to suggest that plateletderived microparticles may deliver platelet mRNAs into other nucleated cells,…”
Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs
Ali, F. Y., Armstrong, P. C. J., Dhanji, A., Tucker, A. T., Paul‐Clark, M. J., Mitchell, J. A., & Warner, T. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183160 · Cited by 143 · cited 5×
“This interaction is believed to sequester PKCa away from its substrates and thereby attenuates platelet functions (Figure 2).(33) These findings identify PPARa as a key mediator of statin and fenofibrate-mediated anti-platelet activity.”
InfluentialThe Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand
Burris, T. P., Montrose, C., Houck, K. A., Osborne, H. E., Bocchinfuso, W. P., Yaden, B. C., Cheng, C., Zink, R. W., Barr, R. J., Hepler, C. D., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007054 · Cited by 136
Raloxifene: A Selective Estrogen Receptor Modulator (SERM) with Multiple Target System Effects
Muchmore, D. B. (2000) · The Oncologist · doi:10.1634/theoncologist.5-5-388 · Cited by 134
Ahuja, H. S., Szántó, A., Nagy, L., & Davies, P. J. (2003) · PubMed · Cited by 132
Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR
Krasowski, M. D., Ni, A., Hagey, L. R., & Ekins, S. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.016 · Cited by 132 · cited 1×
“81 Studies examining the genomic roles for the NRs have shown, for example that 15d-PGJ 2 is an endogenous ligand for PPAR c but it can also act as an antagonist for FXR 82 and phytanic acid has the ability to activate both PPAR a and RXR. 83 Guggulsterone is regarded as an ER agonist but an…”
Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARβ
Ali, F. Y., Davidson, S. J., Moraes, L. A., Traves, S. L., Paul‐Clark, M. J., Bishop‐Bailey, D., Warner, T. D., & Mitchell, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-4395fje · Cited by 132
A tour through the transcriptional landscape of platelets
Schubert, S., Weyrich, A. S., & Rowley, J. W. (2014) · Blood · doi:10.1182/blood-2014-04-512756 · Cited by 129 · cited 1×
“Although devoid of a nucleus, platelets still contain different forms of RNA (mRNA, rRNA, tRNA, and miRNA) and components of the transcription and translation machinery that are derived from megakaryocytes during thrombopoiesis.(16) There is a growing consensus that these RNAs are not subjected to a random transfer by…”
Cholesterol in platelet biogenesis and activation
Wang, N., & Tall, A. R. (2016) · Blood · doi:10.1182/blood-2016-01-631259 · Cited by 122 · cited 1×
“Platelets are known to act as direct contributors towards the progression of CVDs such as atherosclerosis, 86 and their activity becomes considerably enhanced in cases of hyperlipidaemia, 87 obesity, 88 diabetes mellitus, 89 or hypertension.”
Nuclear receptors: Genomic and non-genomic effects converge
Ordóñez-Morán, P., & Muñoz, A. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8579 · Cited by 120
Ligand-specific glucocorticoid receptor activation in human platelets
Moraes, L. A., Paul‐Clark, M. J., Rickman, A., Flower, R. J., Goulding, N. J., & Perretti, M. (2005) · Blood · doi:10.1182/blood-2005-04-1723 · Cited by 117 · cited 7×
“…ER 25,26 • Oestrogen—oestrone (E1), oestradiol (E2) and oestriol (E3) • Reduction in platelet responsiveness however, conflicting results exist 27,28 Prednisolone-treated platelets displayed reduced aggregation and thromboxane B 2 (TxB 2 ) release in response to stimulation by either ADP or…”
InfluentialWalmsley, S. L., Northfelt, D., Melosky, B. L., Conant, M. A., Friedman‐Kien, A. E., & Wagner, B. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199911010-00004 · Cited by 106
The effects of PPAR-? ligand pioglitazone on platelet aggregation and arterial thrombus formation
LI, D., CHEN, K., SINHA, N., ZHANG, X., Wang, Y., SINHA, A., Romeo, F., & Mehta, J. L. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.027 · Cited by 105
Platelet function in hypertension
Haouari, M. E., & Rosado, J. A. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.07.003 · Cited by 102
Bar, J., Tepper, R., Fuchs, J., Pardo, Y., Goldberger, S. B., & Ovadia, J. (1993) · PubMed · Cited by 95
FXR an emerging therapeutic target for the treatment of atherosclerosis
Mencarelli, A., & Fiorucci, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00997.x · Cited by 91 · cited 1×
“NRs including PPARs, LXR, and FXR ligands have all been reported to have anti-atherosclerotic effects, 91,92 coupling this with their anti-platelet effects; there exists the possibility of a potentially new paradigm of treat-ment that can target a range of pathophysiological conditions whilst also…”
Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets
Moraes, L. A., Swales, K. E., Wray, J. A., Damazo, A. S., Gibbins, J. M., Warner, T. D., & Bishop‐Bailey, D. (2007) · Blood · doi:10.1182/blood-2006-05-022566 · Cited by 91 · cited 1×
“Regulation of GPCR-mediated platelet activation by RXR has been associated with its binding to Gaq in a ligand-dependent manner that inhibits Gq-induced Rac activation and intracellular Ca2þ mobilization.(42) Exposure to RXR ligands has also been shown to reduce integrin aIIbb3 outside-in signalling and cytoskeletal r…”
Self-citationAndrogen-mediated sensitivity in platelet aggregation
Johnson, M., RAMEY, E. R., & Ramwell, P. W. (1977) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1977.232.4.h381 · Cited by 91 · cited 1×
“Some studies have specified that the aggregation response of platelets isolated from male rats was stronger in comparison to female rats owing to higher levels of androgenic steroids(46) as platelet aggregation was found to be reduced following castration in male rats and the reversal of these effects following treatm…”
Phytanic acid—an overlooked bioactive fatty acid in dairy fat?
Hellgren, L. I. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05254.x · Cited by 85 · cited 2×
“Studies examining the genomic roles for the NRs have shown, for example that 15d-PGJ2 is an endogenous ligand for PPARc but it can also act as an antagonist for FXR(82) and phytanic acid has the ability to activate both PPARa and RXR.(83) Guggulsterone is regarded as an ER agonist but an antagonist to FXR, GR, and AR,…”
Ng, H. W., Perkins, R., Tong, W., & Hong, H. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110908709 · Cited by 83
Testosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway
Campelo, A. E., Cutini, P. H., & Massheimer, V. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0441 · Cited by 82 · cited 1×
“However, inhibition of platelet aggregation has also been observed following treatment with testosterone, although this was found to be attributed to endothelial NO synthesis and therefore not necessarily a direct effect of testosterone on the platelet AR and platelet activity.(23)”
Matsuda, K., Ruff, A. L., Morinelli, T. A., Mathur, R. S., & Halushka, P. V. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.3.h887 · Cited by 82 · cited 1×
“Two independent studies also confirmed that testosterone causes a significant increase in TXA2 receptor density on the platelet surface, thereby, indirectly increasing platelet responsiveness.(54,55) However, inhibition of platelet aggregation has also been observed following treatment with testosterone, although this…”
Action mechanisms of Liver X Receptors
Gabbi, C., Warner, M. N., & Gustafsson, J.-Α. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.077 · Cited by 81 · cited 1×
“Endogenous ligands for the LXR receptors include oxysterols such as 22(R)-hydroxycholesterol, 24(S)-hydroxycholesterol, 27-hydroxycholesterol, and several synthetic ligands including GW3965 and T0901317 have also been developed.(56,57) Like some of the other NRs, ligands for LXR have been described to have antiinflamm…”
Kwon, S., Kim, I. S., Bae, J.-E., Kang, J.-W., Cho, Y. J., Cho, N. S., & Lee, S. W. (2014) · Vox Sanguinis · doi:10.1111/vox.12158 · Cited by 80
Mean Platelet Volume and Vitamin D Level
Cüre, M. C., Cüre, E., Yuce, S., TarkanYazici, Karakoyun, İ., & Efe, H. (2014) · Annals of Laboratory Medicine · doi:10.3343/alm.2014.34.2.98 · Cited by 77 · cited 4×
“Human platelets have been found to express the VDR. Biochemical fractionation studies along with immuno-electron microscopy analysis identified the VDR to be localized in the soluble and mitochondrial compartment.”
InfluentialSidhu, J. S., Cowan, D., Tooze, J. A., & Kaski, J. C. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.035 · Cited by 74
The “Phantom Effect” of the Rexinoid LG100754: Structural and Functional Insights
Sato, Y., Ramalanjaona, N., Huet, T., Potier, N., Osz, J., Antony, P., Peluso-Iltis, C., Poussin-Courmontagne, P., Ennifar, E., Mély, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015119 · Cited by 73 · cited 1×
“) and form heterodimers,(67) although, the presence of RXR homodimers has also been reported.(68) RXR is well characterized and is involved in the regulation of some of the most vital and fundamental biological processes including cell proliferation, differentiation and death, haematopoiesis, metabolism (glucose, fatt…”
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease
Wu-Wong, J. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00171.x · Cited by 71
The Rexinoid LG100754 Is a Novel RXR:PPARγ Agonist and Decreases Glucose Levels in Vivo
Cesario, R. M., Klausing, K., Razzaghi, H., Crombie, D., Rungta, D., Heyman, R. A., & Lala, D. S. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.8.0677 · Cited by 71
Non‐genomic effects of PPARγ ligands: inhibition of GPVI‐stimulated platelet activation
MORAES, L. A., Spyridon, M., Kaiser, W. J., Jones, C. I., Sage, T., Atherton, R. E., & Gibbins, J. M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03732.x · Cited by 66
Self-citationLXR as a novel antithrombotic target
Spyridon, M., Moraes, L. A., Jones, C. I., Sage, T., Sasikumar, P., Bucci, G., & Gibbins, J. M. (2011) · Blood · doi:10.1182/blood-2010-09-306142 · Cited by 65 · cited 2×
“31 • RXR–Gq interaction and negative regulation of Rac activation to inhibit GPCR-mediated platelet activation • Up-regulation of PKA activity and phosphorylation of VASP S157 in cAMP-and NF jb - dependent manner (see Figure 3 ) VDR 45 • Vitamin D and its metabolites synthetic agonist GW3965…”
Self-citationValéra, M.-C., Gratacap, M.-P., Gourdy, P., Lenfant, F., Cabou, C., Toutain, C. E., Marcellin, M., Saint Laurent, N., Sié, P., Sixou, M., et al. (2012) · Blood · doi:10.1182/blood-2012-01-405498 · Cited by 61
Racial variation in sex steroid hormone concentration in black and white men: a meta‐analysis
Richard, A., Rohrmann, S., Zhang, L., Eichholzer, M., Basaria, S., Selvin, E., Dobs, A. S., Kanarek, N., Menke, A., Nelson, W. G., et al. (2014) · Andrology · doi:10.1111/j.2047-2927.2014.00206.x · Cited by 60
Treatment of hyperlipidaemia with fenofibrate and related fibrates
Filippatos, T., & Milionis, H. J. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1599 · Cited by 56
Ligand Specificity of Nuclear Hormone Receptors: Sifting through Promiscuity
Noy, N. (2007) · Biochemistry · doi:10.1021/bi7018699 · Cited by 55
Platelets in Atherosclerosis and Thrombosis
Schulz, C., & Maßberg, S. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-29423-5_5 · Cited by 53
Prednisolone exerts exquisite inhibitory properties on platelet functions
Liverani, E., Banerjee, S., Roberts, W., Naseem, K. M., & Perretti, M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.006 · Cited by 52 · cited 5×
“This inhibition was not found to be associated with up-regulation of cyclic nucleotides—cyclic adenosine monophosphate (cAMP) or cyclic guanosine monophosphate (cGMP), key inhibitory mediators of platelet activity.(28) Platelet adhesion and thrombus formation under flow on collagen in vitro were also found to be dimin…”
InfluentialPilo, R., Aharony, D., & Raz, A. (1981) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653405 · Cited by 52 · cited 1×
“also reported that acute treatment of rat or human PRP with testosterone potentiates platelet aggregation induced by ADP, adrenaline, collagen, arachidonic acid, and calcium ionophore indicating its rapid non-genomic responses.(48) Two independent studies also confirmed that testosterone causes a significant increase…”
Ali, F. Y., Hall, M. G., Desvergne, B., Warner, T. D., & Mitchell, J. A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.193367 · Cited by 47
Sepe, V., Festa, C., Renga, B., Carino, A., Cipriani, S., Finamore, C., Masullo, D., del Gaudio, F., Monti, M. C., Fiorucci, S., et al. (2016) · Scientific Reports · doi:10.1038/srep19008 · Cited by 44
Endogenous Inhibitory Mechanisms and the Regulation of Platelet Function
Jones, C. I., Barrett, N. E., Moraes, L. A., Gibbins, J. M., & Jackson, D. E. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-307-3_23 · Cited by 41 · cited 3×
“Due to their anucleate nature and mechanistically well characterized and rapid responses, such as aggregation and adhesion, platelets provide an excellent model system to study the acute non-genomic effects of the NRs.(20,21)”
Self-citationAkarasereenont, P., Tripatara, P., Chotewuttakorn, S., Palo, T., & Thaworn, A. (2006) · Platelets · doi:10.1080/09537100600745302 · Cited by 37 · cited 4×
“In one study, acute treatment of platelets ex vivo with either E1 or E3 was found to increase aggregation to adrenaline or ADP.”
InfluentialFarnesoid X Receptor and Its Ligands Inhibit the Function of Platelets
Moraes, L. A., Unsworth, A. J., Vaiyapuri, S., Ali, M. S., Sasikumar, P., Sage, T., Flora, G. D., Bye, A. P., Kriek, N., Dorchies, E., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308093 · Cited by 36
Self-citationRXR Ligands Negatively Regulate Thrombosis and Hemostasis
Unsworth, A. J., Flora, G. D., Sasikumar, P., Bye, A. P., Sage, T., Kriek, N., Crescente, M., & Gibbins, J. M. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309207 · Cited by 32 · cited 6×
“The negative regulation of several platelet activation pathways and processes results in robust inhibition of thrombosis and haemostasis in vivo.(43) As seen with several other NRs, treatment with RXR ligands has also been shown to up-regulate PKA activity and VASP S157 phosphorylation via a process that is dependent…”
InfluentialSelf-citationThe risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease
Nathan, A. S., Sen, S., & Yeh, R. W. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1315101 · Cited by 31 · cited 2×
“The formation of different multi-protein signalling complexes with different localization and distribution patterns across different cell types could offer a high degree of cell and tissue selective action for the NRs but as of yet these are poorly defined.(10,11)”
The platelet as a model system for the acute actions of nuclear receptors
Bishop‐Bailey, D. (2009) · Steroids · doi:10.1016/j.steroids.2009.09.005 · Cited by 30 · cited 2×
“Due to their anucleate nature and mechanistically well characterized and rapid responses, such as aggregation and adhesion, platelets provide an excellent model system to study the acute non-genomic effects of the NRs.(20,21)”
Unsworth, A. J., Kriek, N., Bye, A. P., Naran, K., Sage, T., Flora, G. D., & Gibbins, J. M. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13578 · Cited by 29
Self-citationRondina, M. T., Freitag, M., Pluthero, F. G., Kahr, W. H. A., Rowley, J. W., Kraiss, L. W., Franks, Z. G., Zimmerman, G. A., Weyrich, A. S., & Schwertz, H. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13281 · Cited by 27 · cited 1×
“Treatment of platelets with the endogenous RARa ligand all-transretinoic acid (atRA) disrupts the RARa–Arp2/3 interactions resulting in an inhibition of both cytoskeletal rearrangements and platelet spreading (Figure 3).(41) Recent developments have reported that RARa is capable of regulating protein synthesis (includ…”
Xu, X. Y., Lu, Y., Chen, L., Chen, J., Luo, X., & Shen, X. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.018 · Cited by 25 · cited 14×
“Treatment of platelets with synthetic FXR ligand GW4064 was found to cause a decrease in sample turbidity, 29,39 which was later confirmed to be due to platelet swelling and conversion of platelets to a pro-coagulant state, forming coated-platelets.”
InfluentialDu, H., Hu, H., Zheng, H., Hao, J., Yang, J., & Cui, W. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.005 · Cited by 25
Targeting the vitamin D receptor: advances in drug discovery
Makishima, M., & Yamada, S. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.9.1133 · Cited by 24
Retinoic acid receptor‐α regulates synthetic events in human platelets
Schwertz, H., Rowley, J. W., Zimmerman, G. A., Weyrich, A. S., & Rondina, M. T. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13861 · Cited by 23
Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets
Unsworth, A. J., Bye, A. P., Tannetta, D., Desborough, M., Kriek, N., Sage, T., Allan, H. E., Crescente, M., Yaqoob, P., Warner, T. D., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309135 · Cited by 22
Self-citationRetinoic acid receptor‐α regulates synthetic events in human platelets: reply
Schwertz, H., & Rondina, M. T. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13995 · Cited by 16
The Role of Antiplatelets in Hypertension and Diabetes Mellitus
Ajjan, R., & Grant, P. J. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00431.x · Cited by 12 · cited 1×
“Despite significant advances in the development of antithrombotic therapeutics, they are associated with increased bleeding risk and their efficacy is often compromised in patients suffering from several conditions, such as hypertension and diabetes.(11,72,73) Therefore, more refined and effective therapeutics that en…”
Thematic Minireview Series on Nuclear Receptors in Biology and Diseases
Khan, S., & Lingrel, J. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.196014 · Cited by 12 · cited 1×
“Any deviation from their normal function can lead to the pathological manifestations, such as cancer, diabetes, arthritis, and obesity.(3)”
Update on the use of alitretinoin in treating chronic hand eczema
Scheinfeld, N. S., & Ghasri, P. (2010) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s6495 · Cited by 10
Schaffer, S., Tandon, R., Zipse, H., Siess, W., Schmidt, A., Jamasbi, J., Karshovska, E., Steglich, W., & Lorenz, R. L. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.024 · Cited by 10 · cited 1×
“In support of this, another study reported the ability of endogenous LXR ligand 22(R)-OHcholesterol [but not its stereoisomer 22(S)-OH-cholesterol] to inhibit collagen-induced platelet aggregation and shape change.(58) During thrombus formation, two distinct populations of platelets appear, coaggregated platelets, whi…”
The Role and Mechanisms of Steroid Hormones in Approach–Avoidance Behavior
Frye, C. A., & Rhodes, M. E. (2015) · Routledge eBooks · doi:10.4324/9780203888148.ch7 · Cited by 4
Research works printed but not linked: 1
- Unsworth, 2017, PPARgamma agonists negatively regulate alphaIIbbeta3 integrin outside-in signalling and platelet function through upregulation of protein kinase A activity, J Thromb Haemost, 15, 356, 10.1111/jth.13578 · DOI
Cited by
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Flora, G. D., & Nayak, M. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190925163827 · Cited by 476
Self-citation25-Hydroxycholesterol as a Signaling Molecule of the Nervous System
Odnoshivkina, Y. G., Kuznetsova, E. A., & Petrov, A. M. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922060049 · Cited by 296
“25-HC is a strong natural activator of LXRs [3] present in the plasma membranes (lipid rafts) of some cells [82, 83].”
BackgroundInnate immune receptors in platelets and platelet-leukocyte interactions
Dib, P. R. B., Quirino-Teixeira, A. C., Merij, L. B., Pinheiro, M. B. M., Rozini, S. V., Andrade, F. B., & Hottz, E. D. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0620-701r · Cited by 166
Platelets and diseases: signal transduction and advances in targeted therapy
Tian, Y., Yao, Z., Pang, Y., Zheng, Z., Ma, Y., Zhang, C., & Gao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02198-8 · Cited by 143
“497 Because platelets lack cell nuclei, several NRs present in human platelets can trigger non-genomic effects by physically interacting with cofactors and binding partners.”
Mapping the Azolog Space Enables the Optical Control of New Biological Targets
Morstein, J., Awale, M., Reymond, J., & Trauner, D. H. (2019) · ACS Central Science · doi:10.1021/acscentsci.8b00881 · Cited by 103
Metadata
- Authors
- Unsworth, A. J., Flora, G. D., & Gibbins, J. M.
- Affiliations
- School of Biological Sciences, Institute of Cardiovascular and Metabolic Research, Harborne Building, Whiteknights, Reading RG6 6AS, Berkshire, UK
- Corresponding author
- Gibbins, Jonathan M
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-14
- Volume
- 114
- Issue
- 5
- Pages
- 645-655
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC5915957
- OpenAlex
- W2786404210
- Cited by
- 54
- References
- 108
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 3 · 2023: 10 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cardiovascular Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CentAUR (University of Reading) (acceptedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- British Heart Foundation (RG/15/2/31224)
- Felix Scholarship
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- nuclear receptors, non-genomic signaling, platelets, anucleate cells, antiplatelet activity, ion channel function, intracellular calcium, second messengers
- MeSH terms
- Animals, Blood Platelets, Fibrinolytic Agents, Humans, Ligands, Platelet Aggregation Inhibitors, Protein Binding, Thrombosis, Signal Transduction, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.